Archives

by in
Entry Author Date Location
MD Anderson Leverages IBM Watson in Cancer-Fighting Efforts 04/24/14 Texas
East Coast Biotech Roundup: Gerngross, Akili, Intercept, & More 01/10/14 Boston
San Diego Life Sciences Roundup: Vical, Fate, Arcturus, and More 08/15/13 San Diego
Sunesis Waits Out Suspenseful Final Year of Pivotal Leukemia Trial 07/02/13 San Francisco
FDA Approves Ariad Leukemia Drug Three Months Ahead of Schedule 12/14/12 Boston
East Coast Life Sciences Roundup: Ariad, Celgene, Amgen, More 12/14/12 Boston
Onyx, Millennium, Ariad: Firms to Watch at Hematology Meeting 12/07/12 Boston
FDA Rejects Ariad/Merck Sarcoma Pill, Wall Street Unfazed 06/06/12 New York
San Diego’s Polaris Moves to Late-Stage Test of Drug for Liver Cancer and Other “Arginine-Dependant” Tumors 04/27/11 San Diego
Genzyme-Sanofi Deal Might Be Close, Report Says 02/01/11 Boston
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News 10/22/10 Boston
Agios, Nourished with $130M Celgene Deal, Expanding Staff and Labs to Starve Cancer 08/19/10 Boston
Five Red Flags of a Biotech, Pathway Medical Learns Lessons, Amgen Faces FDA Delay, & More Seattle-Area Life Sciences News 10/22/09 Seattle
Fate Therapeutics Starts First Clinical Trial of Drug to Boost Stem Cell Transplants 05/27/09 San Diego
Riding a Cancer Diagnostics Wave, Genoptix Sees Boom Continuing in 2009 04/01/09 San Diego
Trubion Cuts One-Fourth of Workforce 02/25/09 Seattle
Merck Nabs Harvard Scientist To Replace Rosetta Founder as Oncology Research Head 02/02/09 Boston
Seattle Genetics Drug Passes Safety Test, Trial Continues 12/10/08 Seattle
Blood News: A Quick Rundown of Headlines From the American Society of Hematology 12/09/08 National
Genzyme Asks FDA To Approve Drug for Acute Myeloid Leukemia 11/24/08 Boston
Page 1 of 1